Johnson & Johnson engages in the research, development, manufacture, and sale of various products in the health care field worldwide. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women’s health fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms under JOHNSON’S, AVEENO, CLEAN & CLEAR, NEUTROGENA, RoC, LUBRIDERM, DABAO, VENDÔME, LISTERINE, REACH, BAND-AID, NEOSPORIN, CAREFREE, o.b., STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC names. The company’s Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its principal products comprise REMICADE for the treatment of immune mediated inflammatory diseases; PROCRIT/EPREX to stimulate red blood cell production; RISPERDAL CONSTA for the management of bipolar I disorder and schizophrenia; VELCADE for the treatment of multiple myeloma; CONCERTA for the treatment of attention deficit hyperactivity disorder; PREZISTA for the treatment of HIV/AIDS; ACIPHEX/PARIET, a proton pump inhibitor; and LEVAQUIN for the treatment of bacterial infections. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women’s health products; minimally invasive surgical and sterilization products; blood glucose monitoring and insulin delivery products; professional diagnostic products; and disposable contact lenses. Johnson & Johnson sells its products to the general public, retailers, distributors, wholesalers, health care professionals, and hospitals. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Key Statistics